What is the current Price Target for the Cabaletta Bio Inc stock?

The average Cabaletta Bio Inc target price is $16.13. This is 1,255.04% higher than the current stock price. The highest price target is 2,252.94%, the lowest is 152.10%. 8 Analysts have issued a price target Cabaletta Bio Inc 2026 .

How high will the Cabaletta Bio Inc stock rise?

No reliable answer can be given as to how high the Cabaletta Bio Inc stock will rise. The performance of stocks, including the Cabaletta Bio Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Cabaletta Bio Inc stock today?

The performance of Cabaletta Bio Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Cabaletta Bio Inc stock fall?

The decline in Cabaletta Bio Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Cabaletta Bio Inc Forecast, price target & analysts

$1.19

4.03% yesterday

Nasdaq, Apr 03, 10:00 pm CET

ISIN

US12674W1099

Symbol

CABA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Cabaletta Bio Inc Target price 2025 - Analyst rating & recommendation

Cabaletta Bio Inc Classifications & Recommendation:

Buy

80%

Hold

20%

Cabaletta Bio Inc Price Target

Target Price	$16.13
Price	$1.19
Potential	1,255.04% register free of charge
Number of Estimates	8

	8 Analysts have issued a price target Cabaletta Bio Inc 2026 . The average Cabaletta Bio Inc target price is $16.13. This is 1,255.04% register free of charge higher than the current stock price. The highest price target is $28.00 2,252.94% register free of charge , the lowest is $3.00 152.10% register free of charge .
	A rating was issued by 10 analysts: 8 Analysts recommend Cabaletta Bio Inc to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Cabaletta Bio Inc stock has an average upside potential 2026 of 1,255.04% register free of charge . Most analysts recommend the Cabaletta Bio Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-2.34	-2.43
	41.82%	3.85%
P/E		negative
EV/Sales		negative

3 Analysts have issued a Cabaletta Bio Inc forecast for earnings per share. The average Cabaletta Bio Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-2.34	41.82%
2025	$-2.43 3.85% Unlock
2026	$-2.16 11.11% Unlock
2027	$-2.16 0.00% Unlock
2028	$-1.53 29.17% Unlock
2029	$-0.60 60.78% Unlock

Current	-0.51	95.03%
2025	-0.49 3.92% Unlock
2026	-0.55 12.24% Unlock
2027	-0.55 0.00% Unlock
2028	-0.78 41.82% Unlock
2029	-2.00 156.41% Unlock

Cabaletta Bio Inc...

Current Cabaletta Bio Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Guggenheim	Locked ➜ Locked	Locked	Apr 01 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Apr 01 2025
Morgan Stanley	Locked ➜ Locked	Locked	Apr 01 2025
UBS	Locked ➜ Locked	Locked	Apr 01 2025
Wells Fargo	Locked ➜ Locked	Locked	Apr 01 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 18 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 17 2025

Analyst Rating	Date
Locked Guggenheim: Locked ➜ Locked	Apr 01 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Apr 01 2025
Locked Morgan Stanley: Locked ➜ Locked	Apr 01 2025
Locked UBS: Locked ➜ Locked	Apr 01 2025
Locked Wells Fargo: Locked ➜ Locked	Apr 01 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 18 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 17 2025

Discover more stocks with a high price target

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now